August 15, 2024 – Imidazolidin

The original phase I crizotinib trial (PROFILE1001, NCT00585195), the assay for

Chemexpress August 15, 2024 0 Comments

The original phase I crizotinib trial (PROFILE1001, NCT00585195), the assay for the trial to detect ROS1-rearrangement can be a locally created laboratory-based test and no formal CDx is being developed…

Uncategorized

Have been immunoblotted with anti-AMPK , anti-P-AMP , anti-raptor, anti-P-raptor, anti-mTOR, anti-P-mTOR, anti-S6K

Chemexpress August 15, 2024 0 Comments

Have been immunoblotted with anti-AMPK , anti-P-AMP , anti-raptor, anti-P-raptor, anti-mTOR, anti-P-mTOR, anti-S6K, anti-P-S6K, anti-S6, anti-P-S6, anti-4EBP1, anti-P-4EBP1, or anti-HA antibodies. Anti-GAPDH was employed to verify equal protein loading. The…

The original phase I crizotinib trial (PROFILE1001, NCT00585195), the assay for

Have been immunoblotted with anti-AMPK , anti-P-AMP , anti-raptor, anti-P-raptor, anti-mTOR, anti-P-mTOR, anti-S6K

You Missed

2-Chloro-N-[2-(2,4-dioxo-thiazolidin-3-yl)-ethyl]-acetamide

2-chloro-N-[1-(3,4-dipropoxyphenyl)ethyl]acetamide

2-chloro-N-[1-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methylpropyl]acetamide

1,2-Dimethyl-3-propylimidazolium bis(trifluoromethylsulfonyl)imide (CAS 169051-76-7)